Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar-Apr;114(2):116-119.

Non-Pharmacologic Interventions for Persons with Dementia

Marla Berg-Weger  1 , Daniel B Stewart  2
Affiliations

Non-Pharmacologic Interventions for Persons with Dementia

Marla Berg-Weger et al. Mo Med. 2017 Mar-Apr.

Abstract

Affecting over 100,000 older Missourians, cognitive impairment is of concern for all health care providers. With no available pharmacologic treatments to eradicate/diminish symptoms, professionals and families need non-pharmacologic behavioral interventions to enhance individuals' quality-of-life and decrease the number and intensity of dementia-related behavioral symptoms. This paper provides an overview of available evidence-based non-pharmacologic interventions and strategies that can be delivered in both the community and facility setting, including reminiscence, validation, and cognitive stimulation therapies.

PubMed Disclaimer

References

    1. U.S. Census Bureau. Quick facts. Washington, D.C: U.S. Census Bureau; 2015. www.census/gov/quickfacts/table/PST045215/29.
    1. United Health Foundation. America’s health rankings® senior report. 2016. Retrieved from: http://assets.americashealthrankings.org/app/uploads/final-report-senior....
    1. Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;2016;12(4):459–509. - PubMed
    1. Rodda J, Morgan S, Walker Z. Are cholinesterase inhibitors effective in the management of the behavior and psychological symptoms of dementia in Alzheimer’s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Int Psychogeriatr. 2009;5:813–824. - PubMed
    1. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA. 2002;288(12):1475–1483. - PubMed

LinkOut - more resources